ºÒÀÓ Ä¡·áÁ¦ ½ÃÀå : ¾àÁ¦ À¯Çüº°, Åõ¿© °æ·Îº°, ¼ºº°, À¯Åë ä³Îº°, Áö¿ªº°
Infertility Drugs Market, By Drug Type, By Route of Administration, By Gender, By Distribution Channel, By Geography
»óǰÄÚµå : 1672890
¸®¼­Ä¡»ç : Coherent Market Insights
¹ßÇàÀÏ : 2025³â 02¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹®
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,500 £Ü 6,511,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 7,000 £Ü 10,128,000
PDF (Multi User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 7¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 10,000 £Ü 14,469,000
PDF (Enterprise User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°è ºÒÀÓ Ä¡·áÁ¦ ½ÃÀåÀº 2025³â 41¾ï 8,000¸¸ ´Þ·¯, 2032³â¿¡´Â 66¾ï 2,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 2025-2032³â ¿¬Æò±Õ ¼ºÀå·ü(CAGR) 6.8%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

º¸°í ¹üÀ§ º¸°í¼­ »ó¼¼ ³»¿ë
±âÁØ ¿¬µµ 2024³â 2025³â ½ÃÀå ±Ô¸ð 41¾ï 8,000¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2020-2024³â ¿¹Ãø ±â°£ 2025-2032³â
¿¹Ãø ±â°£(2025-2032³â) CAGR 6.80% 2032³â ±Ý¾× ¿¹Ãø 66¾ï 2,000¸¸ ´Þ·¯
±×¸². ºÒÀÓÄ¡·áÁ¦ ½ÃÀå Á¡À¯À²(%), 2025³â Áö¿ªº° ½ÃÀå Á¡À¯À²
Infertility Drugs Market-IMG1

ºÒÀÓÀ̶õ Á¤±âÀûÀ¸·Î ¹«¹æºñ »óÅÂÀÇ ¼º°ü°è¸¦ ÇØµµ ÀÚ¿¬ÀûÀ¸·Î ¾ÆÀ̸¦ ÀÓ½ÅÇÒ ¼ö ¾ø´Â »óŸ¦ ¸»ÇÕ´Ï´Ù. Àü ¼¼°èÀûÀ¸·Î ºÒÀÓÀº »çȸÀûÀ¸·Î³ª °Ç°­ÀûÀ¸·Î ³Î¸® ÆÛÁ® ÀÖ´Â ¹®Á¦ÀÔ´Ï´Ù. ºÒÀÓÄ¡·áÁ¦ ½ÃÀåÀÇ ¼ºÀåÀ» ÁÖµµÇϰí ÀÖ´Â °ÍÀº ³²³à ¸ðµÎ ºÒÀÓÀÇ ¹ßº´·üÀÌ Áõ°¡Çϰí ÀÖ´Ù´Â Á¡ÀÔ´Ï´Ù. ½ºÆ®·¹½º, »ýȰ½À°ü º¯È­, ºñ¸¸, ¼ºº´, À¯ÀüÀû ÀÌ»ó µîÀÇ À§Çè ¿äÀÎÀÌ ³²¼º ºÒÀÓ°ú ¿©¼º ºÒÀÓÀÇ À¯º´·ü Áõ°¡¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. º¸Á¶»ý½Ä¼ú ±â¼úÀÇ ¹ßÀü°ú ºÒÀÓ Ä¡·áÁ¦ÀÇ ¼º°ø·ü Çâ»óÀº ¼ö¹é¸¸ ¸íÀÇ ºÒÀÓ ºÎºÎ¿¡°Ô Èñ¸ÁÀ» ÁÖ°í ÀÖ½À´Ï´Ù. ¿©·¯ Á¦¾àȸ»ç´Â ¹è¶õ Àå¾Ö, È£¸£¸ó ºÒ±ÕÇü, ±âŸ ºÒÀÓ°ú °ü·ÃµÈ ¹®Á¦¸¦ Ä¡·áÇÒ ¼ö ÀÖ´Â ´Ù¾çÇÑ ºÒÀÓ Ä¡·áÁ¦¸¦ Á¦°øÇÕ´Ï´Ù.

½ÃÀå ¿ªÇÐ

¼¼°è ºÒÀÓ Ä¡·áÁ¦ ½ÃÀåÀÇ ¼ºÀåÀº ºÒÀÓ·ü Áõ°¡, ºÎÀΰú ÁúȯÀÇ À¯º´·ü Áõ°¡, ºÒÀÓ ¹× Ä¡·á¹ý¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, ÀÇ·áºñ ÁöÃâ Áõ°¡, ºÒÀÓ Ä¡·á¹ýÀÇ ±â¼ú ¹ßÀü, Á¤ºÎ ¹× ±âŸ ±â°üÀÇ ÀçÁ¤ Áö¿ø µîÀÇ ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ±×·¯³ª ºÒÀÓ Ä¡·áÁ¦ÀÇ ³ôÀº ºñ¿ë, ºÒÀÓ Ä¡·áÁ¦¿Í °ü·ÃµÈ ÇÕº´Áõ ¹× À§Çè, ¾ö°ÝÇÑ ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©, ÀϺΠ±¹°¡ÀÇ ¹®È­Àû, »çȸÀû À庮 µîÀÇ ¿äÀÎÀÌ ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. °³¹ßµµ»ó±¹ÀÇ ºÒÀÓÄ¡·áÁ¦ Ŭ¸®´Ð°ú ü¿Ü¼öÁ¤ Ŭ¸®´ÐÀÇ ¼ö°¡ Áõ°¡ÇÔ¿¡ µû¶ó À¯¸®ÇÑ ¼ºÀå ±âȸ¸¦ Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù. ½ÅÈï±¹Àº ÀÇ·á°ü±¤ Áõ°¡¿Í À¯¸®ÇÑ ±ÔÁ¦·Î ÀÎÇØ Å« ¼ºÀå ÀáÀç·ÂÀ» °¡Áö°í ÀÖ½À´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

¼¼°èÀÇ ºÒÀÓ Ä¡·áÁ¦ ½ÃÀåÀ» »ó¼¼ÇÏ°Ô ºÐ¼®ÇßÀ¸¸ç, 2024³âÀ» ±âÁØ ¿¬µµ·Î ÇÏ¿© ¿¹Ãø ±â°£(2025-2032³â) ½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯)¿Í ¿¬Æò±Õ ¼ºÀå·ü(CAGR)¿¡ ´ëÇØ Á¶»ç ºÐ¼®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

¶ÇÇÑ, ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀû ¼öÀÍ ±âȸ¸¦ ¹àÈ÷°í, ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.

¶ÇÇÑ ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÇ °æÀï Àü·« µî¿¡ ´ëÇÑ ÁÖ¿ä °íÂûÀ» Á¦°øÇÕ´Ï´Ù.

¼¼°è ºÒÀÓÄ¡·áÁ¦ ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏÀ» ±â¾÷ ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, ½ÇÀû, Àü·« µîÀÇ ÆÄ¶ó¹ÌÅ͸¦ ±âÁØÀ¸·Î Á¤¸®ÇÏ¿© ¼ö·ÏÇÏ¿´½À´Ï´Ù.

Á¶»ç ´ë»ó ÁÖ¿ä ±â¾÷À¸·Î´Â Merck, Ferring Pharmaceuticals, LIVZON Pharmaceutical Group Inc, AbbVie Inc, MSD µîÀÌ ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­ÀÇ ÅëÂû·ÂÀ» ÅëÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀº ÇâÈÄ Á¦Ç° Ãâ½Ã, À¯ÇüÈ­, ½ÃÀå È®´ë, ¸¶ÄÉÆÃ Àü·«¿¡ ´ëÇÑ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.

¼¼°è ºÒÀÓ Ä¡·áÁ¦ ½ÃÀå º¸°í¼­´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô ½ÃÀå ÁøÃâ±â¾÷, À繫 ºÐ¼®°¡ µî ÀÌ »ê¾÷ÀÇ ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀº ¼¼°è ºÒÀÓÄ¡·áÁ¦ ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤À» ¿ëÀÌÇÏ°Ô ÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¸ñÀû°ú ÀüÁ¦Á¶°Ç

Á¦2Àå ½ÃÀå Àü¸Á

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

Á¦4Àå ¼¼°èÀÇ ºÒÀÓ Ä¡·áÁ¦ ½ÃÀå - Äڷγª¹ÙÀÌ·¯½º(COVID-19) ÆÒµ¥¹ÍÀÇ ¿µÇâ

Á¦5Àå ¼¼°èÀÇ ºÒÀÓ Ä¡·áÁ¦ ½ÃÀå, ¾àÁ¦ À¯Çüº°, 2020-2032³â(10¾ï ´Þ·¯)

Á¦6Àå ¼¼°èÀÇ ºÒÀÓ Ä¡·áÁ¦ ½ÃÀå, Åõ¿© °æ·Îº°, 2020-2032³â(10¾ï ´Þ·¯)

Á¦7Àå ¼¼°èÀÇ ºÒÀÓ Ä¡·áÁ¦ ½ÃÀå, ¼ºº°, 2020-2032³â(10¾ï ´Þ·¯)

Á¦8Àå ¼¼°èÀÇ ºÒÀÓ Ä¡·áÁ¦ ½ÃÀå, À¯Åë ä³Îº°, 2020-2032³â(10¾ï ´Þ·¯)

Á¦9Àå ¼¼°èÀÇ ºÒÀÓ Ä¡·áÁ¦ ½ÃÀå, Áö¿ªº°, 2020-2032³â(10¾ï ´Þ·¯)

Á¦10Àå °æÀï ±¸µµ

Á¦11Àå ¾Ö³Î¸®½ºÆ® Ãßõ »çÇ×

Á¦12Àå Âü°í ¹®Çå°ú Á¶»ç ¹æ¹ý

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Infertility Drugs Market is estimated to be valued at USD 4.18 Bn in 2025 and is expected to reach USD 6.62 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6.8% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 4.18 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 6.80% 2032 Value Projection: USD 6.62 Bn
Figure. Infertility Drugs Market Share (%), By Region 2025
Infertility Drugs Market - IMG1

Infertility refers to the inability to conceive a child naturally after a period of regular unprotected sexual intercourse. Globally, infertility is a widely prevalent issue with societal and health implications. Global infertility drugs market growth is driven by increasing incidence of infertility among both men and women. Risk factors like rising stress levels, lifestyle changes, obesity, sexually transmitted diseases, and genetic abnormalities have contributed to growing prevalence of both male and female infertility. Advancements in assisted reproductive technologies and increasing success rates of infertility treatment procedures have provided hope to millions of struggling couples. Several pharmaceutical companies offer a wide range of infertility medications that can treat ovulation disorders, hormonal imbalances, and other fertility-related issues.

Market Dynamics:

Global infertility drugs market growth is driven by factors such as rising infertility rates, increasing prevalence of gynecological disorders, growing awareness about infertility and treatment options, rising healthcare expenditure, technological advancements in fertility treatment procedures, and the financial assistance provided by governments and other organizations. However, factors such as high cost of infertility treatment, complications and risk associated with infertility therapy, stringent regulatory framework, and cultural and social barriers in some nations can hamper the market growth. Growing number of fertility and IVF clinics across developing regions can offer lucrative growth opportunities. Emerging economies offer significant growth potential due to increasing medical tourism and favorable regulations.

Key Features of the Study:

This report provides in-depth analysis of the global infertility drugs market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global infertility drugs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Merck, Ferring Pharmaceuticals, LIVZON Pharmaceutical Group Inc., AbbVie Inc., and MSD

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global infertility drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global infertility drugs market

Detailed Segmentation-

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Infertility Drugs Market - Impact of Coronavirus (COVID-19) Pandemic

5. Global Infertility Drugs Market, By Drug Type, 2020 - 2032, (USD Bn)

6. Global Infertility Drugs Market, By Route of Administration, 2020 - 2032, (USD Bn)

7. Global Infertility Drugs Market, By Gender, 2020 - 2032, (USD Bn)

8. Global Infertility Drugs Market, By Distribution Channel, 2020 - 2032, (USD Bn)

9. Global Infertility Drugs Market, By Region, 2020 - 2032, (USD Bn)

10. Competitive Landscape

11. Analyst Recommendations

12. References and Research Methodology

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â